# Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation

> **NCT00592306** · PHASE3 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Lung Transplant

## Interventions

- **DRUG:** thymoglobulin (intraoperative)
- **DRUG:** thymoglobulin (postoperative)

## Key facts

- **NCT ID:** NCT00592306
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-01
- **Primary completion:** 2009-09
- **Final completion:** 2010-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of enrollment
- **Last updated:** 2020-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00592306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00592306, "Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00592306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*